Multiplex Bio /
mass cytometry business
Multiplex Bio to acquire mass cytometry business




Source for the buyer and target: Standard BioTools Inc.
For the buyer and target.
“Pursuant to the Purchase Agreement, on the terms and subject to the conditions set forth therein, Multiplex Bio will acquire the mass cytometry business (the “Business”) of the Company (collectively, the “Transaction”).”
Published 28 Jul 2026
Open the sourceWhat happened
Standard BioTools Inc. agreed to sell its mass cytometry business to Multiplex Bio Inc. for an aggregate purchase price of $5 million, subject to customary adjustments. Payment will be made through a promissory note, and Standard BioTools Inc. will not receive cash consideration at closing. [01]
Standard BioTools Inc. could receive an additional $5 million if Multiplex Bio Inc. completes a qualifying sale transaction within ten years of closing. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Multiplex Bio to acquire mass cytometry business
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
Deal Web
Every firm and person on this deal, and how they connect. Open any name to see their other deals.
Agreement signed · Multiplex Bio / mass cytometry business deal (Agreement signed, published 28 Jul 2026).
Published 28 Jul 2026- Published by Standard BioTools Inc.
Deal Web as a list
- Multiplex Bio (Buyer) buyer this deal. Multiplex Bio: 1 deal on Carrywatch.
By email · Weekly